Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A financial planner can help you navigate retirement planning, ensuring you have the right strategies in place for a secure future.
25,466 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...
Boeing, Honeywell, and 3M all fell in after-hours trading as Q4 results rolled out, signaling divergent paths. This p...
XRP faces a critical moment as it again tests the $1.50 resistance, with bulls hoping for a sustained breakout while ...
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
Bitcoin hits $64,000 as a viral altcoin skyrockets daily sends shockwaves through the market. Traders weigh liquidity...
Investors are valuing AI-enabled capacity in Bitcoin mining at a premium before construction is complete, marking a s...
XRP is under renewed pressure after a harsh stretch of declines, with traders weighing the risk of deeper losses agai...
Allstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
A once-hot stock that rode the COVID surge now sits far from its peak. This piece breaks down how wall street erases ...
MARA shares rose about 8% midday as Bitcoin bounced, reviving the long-running debate over whether the crypto miner i...